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Introduction
In January of 2007 an international scientific conference
"Responding to Infectious Diseases in the Border Regions
of South and Southeast Asia" was conducted by our col-
laborative group, and hosted by the Faculty of Tropical
Medicine of Mahidol University in Bangkok, Thailand.
The conference was something of a landmark, in that it
attempted to bring together groups and individuals work-
ing on infectious diseases in Burma/Myanmar proper,
those working on her border regions, and concerned rep-
resentatives and scientists from the Burma neighbor states
of Thailand, China, India and Bangladesh. Some 190 rep-
resentatives from 9 countries attended, with representa-
tives from Government, Academia, NGOs, relief groups
including MSF France and MSF Switzerland, WHO SEARO
Office and representative from WHO and UNAIDS in
Burma/Myanmar, the U.S. CDC and USAID, and Euro-
pean donors including DFID. The diseases of concern
included HIV/AIDS, TB, malaria, neglected tropical dis-
eases prevalent in Burma including filariasis, anthrax, Jap-
anese encephalitis, and the emergent epidemic of Avian
Influenza. What made this effort unique, and perhaps
uniquely challenging, is that Burma/Myanmar was at the
time, and remains at this writing, a deeply divided coun-
try, where scientific and humanitarian efforts have all too
often been forced to choose between work "inside" the
country and so with the approval or engagement of the
ruling military junta, or "outside" the control of the junta,
in partnership with non-Burman ethnic minority and
democratic forces. As a measure of how divided the coun-
try can be, those on differing ends of the political spec-
trum do not agree on the name for country or her major
cities and states. Those presenting data on Myanmar often
have little accurate or current information on the border
regions and may face government censorship over what
data they do have – while groups working on the borders
often know a great deal more about their areas of opera-
tion – but may be unwilling to openly divulge where and
in what domains they are active for security reasons.
While all agree that Burma's peoples are in urgent need of
health interventions and greatly expanded efforts to con-
trol and mitigate infectious diseases, the debate about
how best to deliver those interventions has also been
polarized, and there have been few, if any, opportunities
for those engaged in the many and varied efforts under-
way to meet, share their efforts and undertakings, and dis-
cuss the potential for comprehensive responses. Given the
politicization of humanitarian and health efforts in this
troubled country, it seemed prudent to engage the many
entities involved in a scientific meeting, where the dis-
eases of importance could be addressed by the best avail-
able science and public health program approaches, and
where health care providers working in challenging polit-
ical environments might meet in a shared spirit of profes-
sionalism, mutual respect, and tolerance.
The conference was "off the record" to maximize the secu-
rity of those most vulnerable, such as representatives of
ethnic nationality health organizations whose political
leaders have not signed cease-fire agreements with the rul-
ing junta, and representatives from groups working under
junta auspices in Burma proper, and so subject to surveil-
lance, as is generally the case for Burmese professionals
when they attend international meetings. Two exceptions
were made to this rule: we agreed to a post-conference ses-
sion with the press to share de-attributed outcomes with
the lay media, and we offered to the speakers and partici-
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talks into manuscripts for this special series in Conflict and
Health. The papers presented here are among the core out-
comes of the conference, and we are delighted to be able
to present them to a wider audience.
Infectious diseases in Burma and on her borders
What have we learned from bringing together the many
players involved in Burma's health crisis? First, there is no
debate that Burma's health care system is facing enormous
difficulties and is currently unable to effectively respond
to her health and humanitarian crisis. Malnutrition is
widespread, and UNICEF estimates are that chronic mal-
nutrition may affect up to a third of Burma's children,
markedly increasing their susceptibility to infectious dis-
eases. In 2000, Burma's health care system was ranked
190th out of 191 nations by WHO[1]. Malaria is a major
killer among infectious diseases, and Burma accounted for
nearly half of all malaria deaths in the SEARO region
(which includes India) despite having only a fraction of
the regional population. Under-five childhood mortality
was reported to be 106 per 1000 live births in 2006, com-
pared to 21 per 1000 live births in Thailand and is known
to be substantially higher in Eastern Burma's conflict
areas[2]. These indicators are outcomes of the exception-
ally low levels of health expenditure by the ruling State
Peace and Development Council, or SPDC. UNICEF
reported that SPDC spending on health care in Burma
amounted to U.S. $0.40 cents per person per year in 2005,
compared to U.S. $61 in neighboring Thailand[2]. There
is a broad consensus on need within the country, and gen-
eral recognition that the health crises of Burma have
implications for her neighbors.
The regional impact of Burma's health crisis was
addressed by speakers from Thailand, China, India, and
Bangladesh. Examples of these challenges include the ris-
ing regional rates of MDR-TB and MDR-malaria. For both
India and Thailand, the provinces with the highest rates of
MDR-TB in their national programs were Burma border
states. As Richards et al, point out in their malaria piece,
the high prevalence of p. falciparum malaria in eastern
Burma continues to serve as a large reservoir that likely
constitutes a source of infection for neighboring coun-
tries. In addition, fake artesunates circulating in upper
Burma's malaria zones have the potential to undermine
the viability of this critical new class of agents[3]. In the
context of HIV/AIDS, the Burma border zones of Yunnan
in China, and Manipur and Nagaland in the Indian
Northeast were all reported to be those countries most
HIV – affected states and provinces. And in a strikingly
similar and likely highly correlated interaction, Yunnan,
the Indian Northeast, and Northern Thailand, all Burma
border regions, were also the three nations most affected
areas by another Burmese export – methampheta-
mines[4]. Dave Mathieson of Human Rights Watch
reported at the conference that Burma accounts for
roughly 25% of the amphetamines produced in Asia and
that seizures in her neighbors had increased in 2006[3].
The future
Taken together, these infectious disease realities under-
scored an obvious but critical message of the conference:
infectious diseases do not respect man-made borders and
political divisions – and single country approaches are
unlikely to succeed in regional outbreaks. The case was
made that this is particularly true for the unfortunate peo-
ple of Burma, more than 1.2 million of whom have fled
their homeland in recent years to seek work, food, secu-
rity, and to escape conflict. With population flows of this
magnitude, the unresolved health threats of Burma
quickly become access to care issues for Burmese migrants
and refugees in neighbor states, a reality highlighted by
several speakers who provide health care services for these
populations.
Despite these many challenges, a number of groups pre-
sented impressive program successes in difficult environ-
ments. Groups working inside Burma from cross-border
approaches launched from Thailand into Eastern Burma,
from Yunnan into the northern Burmese Kachin and Shan
States, and those working in western Burma from the
Indian Northeast reported on primary health care, repro-
ductive health care, integrated malaria control, and HIV/
AIDS efforts using cross-border approaches. Such efforts
made it abundantly clear the "inside" vs "outside" distinc-
tion makes little sense when discussing these programs.
They deliver services inside Burma to populations includ-
ing internally displaced populations (IDPs) and families
in cease-fire zones that are very much "inside" the coun-
try. The major distinction with these groups is that most
do not operate under SPDC control or sanction – and so
can reach populations not served by SPDC or its affiliates.
A further distinction was found in data reported from the
Mae Tao Clinic, which while on the Thai side of the Thai-
Burma border serves an ever increasing proportion of Bur-
mese from inside Burma proper who are neither migrants
nor refugees – but health care seekers who come to Thai-
land for care unavailable or unaffordable at home.
Patients from Burma accounted for some 47% of all Mae
Tao Clinic attendees in 2005, including 72% of p. falci-
parum malaria cases, 75% of all patients requiring blood
transfusions and 51% of all the clinic's HIV positive cli-
ents[5]. Burmese people are "voting with their feet" and
making the long, arduous, and often dangerous journey
to Thailand to seek health care.
Since the January conference Burma/Myanmar has seen
the largest protests against military rule since the 1988
uprising: The Saffron Revolution of September 2007.Page 2 of 3
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Sparked initially by sharp rises in energy costs, which fur-
ther impoverished an already threatened population, the
non-violent uprising took on national scale when it was
led by Burma's revered Buddhist monks[6]. The brutal
crackdown which followed the uprising further isolated
the military government, and brought heightened atten-
tion to the courage and the suffering of Burma's people. It
also brought markedly increased calls for humanitarian
assistance for the people of Burma, and numerous donors
have responded with promised aid in humanitarian assist-
ance and in health. While doubtless these efforts will save
lives, it remains the case that Burma's humanitarian crisis
is a man-made one: it is the direct outcome of military
misrule, not simple poverty alone, and of the massive
divestment in health and education, and in public sector
spending more broadly, that has characterized the current
regime of General Than Shwe and the SPDC. In addition
to limiting spending on health care, the junta has also
imposed tight restrictions on humanitarian assistance,
and there is no evidence to date that these restrictions
have eased in wake of Saffron Revolution. Tragically, the
opposite seems to be the case: at this writing even more
restrictive policy documents are circulating among NGOs
in Rangoon, and the junta may make humanitarian assist-
ance even more difficult to deliver through traditional
channels[7]. Beyond these restrictions, ongoing forced
displacement, forced labor, and other human rights viola-
tions continue to take their toll especially on the health
status of ethnic minority border populations[8]. Cross-
border approaches remain viable alternatives to access
these most vulnerable border populations and those most
likely to impact neighboring countries, but donor reluc-
tance to support such efforts may hamper the ability of
many groups to provide this assistance. In the short term,
these realities suggest Burma will remain vulnerable to
new and existing infectious disease threats – and her
neighbors will continue to be challenged by the ongoing
suffering of the Burmese people.
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